Impact of COVID-19 on Pharmaceutical Social Media Influencer Activity – June 2020

The highly contagious coronavirus (SARS-CoV-2), dubbed COVID-19 (formerly 2019-nCoV), which emerged at the close of 2019, has led to a medical emergency across the world, with the World Health Organization (WHO) officially declaring the novel coronavirus a pandemic on March 11, 2020. This report analyzes GlobalData’s social media Influencer dashboards to understand Influencer trends since the pandemic began and what key Influencers are discussing online about COVID-19.

Scope

This report analyzes Influencer trends since the pandemic began and what assesses what key Influencers are discussing online about the virus.

The report includes 10 Influencer dashboards:

•Eight therapy areas: Cardiovascular, Metabolic Disorders, Immunology, Infectious Diseases, Neurology, Oncology, Ophthalmology, and Biosimilars

•Digital Pharma

•Macroeconomics

This report will be updated every month.

This report analyses May 2020 activity, with April included as a comparison.

Reasons to buy

• View Influencer trends across different therapy areas and themes since the COVID-19 pandemic began.

• Stay up to date on what key Influencers are discussing online about the virus.

• Identify key Influencers across therapy areas and themes.

Table of Contents

Impact of COVID-19 on Social Media Influencers

− Cardiovascular

− Metabolic Disorders

− Immunology

− Infectious Diseases

− Neurology

− OncologyOphthalmology

− Digital Pharma

− Macroeconomic Influencers

Appendix

− Abbreviations

− Methodology

− Related Reports

− About the Authors

− About GlobalData

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports